Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in Atherosclerosis

Retrieve available abstracts of 92 articles:
HTML format
Text format



Single Articles


    March 2017
  1. MATSUNAGA M, Yatsuya H, Iso H, Yamashita K, et al
    Similarities and differences between coronary heart disease and stroke in the associations with cardiovascular risk factors: The Japan Collaborative Cohort Study.
    Atherosclerosis. 2017 Mar 6. pii: S0021-9150(17)30093.
    PubMed     Text format     Abstract available


    February 2017
  2. LIU LP, Cheng K, Ning MA, Li HH, et al
    Association between peripheral blood cells mitochondrial DNA content and severity of coronary heart disease.
    Atherosclerosis. 2017 Feb 20. pii: S0021-9150(17)30065.
    PubMed     Text format     Abstract available


    December 2016
  3. RASMUSSEN KL
    Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review.
    Atherosclerosis. 2016;255:145-155.
    PubMed     Text format     Abstract available


    October 2016
  4. LU Y, Cheng Z, Zhao Y, Chang X, et al
    Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis.
    Atherosclerosis. 2016;254:215-227.
    PubMed     Text format     Abstract available


    September 2016
  5. GUO XY, Li N, Du X, Bai R, et al
    Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis.
    Atherosclerosis. 2016;254:1-7.
    PubMed     Text format     Abstract available


  6. ELAJAMI TK, Giuseffi J, Avila MD, Hovnanians N, et al
    Parity, coronary heart disease and mortality in the old order Amish.
    Atherosclerosis. 2016;254:14-19.
    PubMed     Text format     Abstract available


  7. SANTOS-GALLEGO CG, Wallert M, Peter K
    Myocardial infarction caused by surgery: Blame inflammation not the surgeon.
    Atherosclerosis. 2016 Sep 1. pii: S0021-9150(16)31312.
    PubMed     Text format    


    August 2016
  8. ZENG L, Dang TA, Schunkert H
    Genetics links between transforming growth factor beta pathway and coronary disease.
    Atherosclerosis. 2016 Aug 25. pii: S0021-9150(16)31290.
    PubMed     Text format     Abstract available


    July 2016
  9. VISSERS LE, Waller MA, van der Schouw YT, Hebert JR, et al
    The relationship between the dietary inflammatory index and risk of total cardiovascular disease, ischemic heart disease and cerebrovascular disease: Findings from an Australian population-based prospective cohort study of women.
    Atherosclerosis. 2016 Jul 30. pii: S0021-9150(16)31230.
    PubMed     Text format     Abstract available


  10. YUBERO-SERRANO EM, Delgado-Lista J, Alcala-Diaz JF, Garcia-Rios A, et al
    A dysregulation of glucose metabolism control is associated with carotid atherosclerosis in patients with coronary heart disease (CORDIOPREV-DIAB study).
    Atherosclerosis. 2016 Jul 16. pii: S0021-9150(16)31204.
    PubMed     Text format     Abstract available


    June 2016
  11. DISTELMAIER K, Schrutka L, Wurm R, Seidl V, et al
    Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction.
    Atherosclerosis. 2016 Jun 24. pii: S0021-9150(16)30282.
    PubMed     Text format     Abstract available


  12. LOUWE MC, Lammers B, Frias MA, Foks AC, et al
    Abca1 deficiency protects the heart against myocardial infarction-induced injury.
    Atherosclerosis. 2016;251:159-163.
    PubMed     Text format     Abstract available


  13. MENZEL J, di Giuseppe R, Biemann R, Wittenbecher C, et al
    Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study.
    Atherosclerosis. 2016 Jun 2. pii: S0021-9150(16)30243.
    PubMed     Text format     Abstract available


    May 2016
  14. MANTAS D, Markopoulos C
    Screening mammography: Usefulness beyond early detection of breast cancer.
    Atherosclerosis. 2016;248:1.
    PubMed     Text format    


  15. PARK SJ, Yang HM, Seo KW, Choi SY, et al
    The relationship between coronary atherosclerosis and body fat distribution measured using dual energy X-ray absorptiometry.
    Atherosclerosis. 2016;248:190-5.
    PubMed     Text format     Abstract available


  16. YONGSAKULCHAI P, Settasatian C, Settasatian N, Komanasin N, et al
    Association of combined genetic variations in PPARgamma, PGC-1alpha, and LXRalpha with coronary artery disease and severity in Thai population.
    Atherosclerosis. 2016;248:140-8.
    PubMed     Text format     Abstract available


  17. CHENG JM, Oemrawsingh RM, Garcia-Garcia HM, Boersma E, et al
    PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study.
    Atherosclerosis. 2016;248:117-22.
    PubMed     Text format     Abstract available


  18. GLEISSNER CA
    Translational atherosclerosis research: From experimental models to coronary artery disease in humans.
    Atherosclerosis. 2016;248:110-6.
    PubMed     Text format     Abstract available


  19. CAHILL PA, Redmond EM
    Vascular endothelium - Gatekeeper of vessel health.
    Atherosclerosis. 2016;248:97-109.
    PubMed     Text format     Abstract available


    April 2016
  20. MIRANDA CH, de Carvalho Borges M, Schmidt A, Marin-Neto JA, et al
    Evaluation of the endothelial glycocalyx damage in patients with acute coronary syndrome.
    Atherosclerosis. 2016;247:184-8.
    PubMed     Text format     Abstract available


  21. OEMRAWSINGH RM, Cheng JM, Garcia-Garcia HM, Kardys I, et al
    High-sensitivity Troponin T in relation to coronary plaque characteristics in patients with stable coronary artery disease; results of the ATHEROREMO-IVUS study.
    Atherosclerosis. 2016;247:135-41.
    PubMed     Text format     Abstract available


  22. DAI J, Tian J, Hou J, Xing L, et al
    Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome: An optical coherence tomography study.
    Atherosclerosis. 2016;247:111-7.
    PubMed     Text format     Abstract available


  23. NAITO R, Miyauchi K, Konishi H, Tsuboi S, et al
    Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984-2008.
    Atherosclerosis. 2016;247:105-10.
    PubMed     Text format     Abstract available


  24. SKAGEN K, Troseid M, Ueland T, Holm S, et al
    The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
    Atherosclerosis. 2016;247:64-9.
    PubMed     Text format     Abstract available


  25. CAVALCANTE R, Bittencourt MS, Pinheiro TL, Falcao BA, et al
    Validation of coronary computed tomography angiography scores for non-invasive assessment of atherosclerotic burden through a comparison with multivessel intravascular ultrasound.
    Atherosclerosis. 2016;247:21-7.
    PubMed     Text format     Abstract available


    March 2016
  26. RALLIDIS LS, Triantafyllis AS, Tsirebolos G, Katsaras D, et al
    Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
    Atherosclerosis. 2016;249:17-21.
    PubMed     Text format     Abstract available


  27. PETERS SA, Singhateh Y, Mackay D, Huxley RR, et al
    Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: A systematic review and meta-analysis.
    Atherosclerosis. 2016;248:123-131.
    PubMed     Text format     Abstract available


  28. CUI R, Iso H, Yamagishi K, Saito I, et al
    Trends in the proportions of stroke subtypes and coronary heart disease in the Japanese men and women from 1995 to 2009.
    Atherosclerosis. 2016;248:219-223.
    PubMed     Text format     Abstract available


    February 2016
  29. ZHONG C, You S, Zhong X, Chen GC, et al
    Retinal vein occlusion and risk of cerebrovascular disease and myocardial infarction: A meta-analysis of cohort studies.
    Atherosclerosis. 2016;247:170-176.
    PubMed     Text format     Abstract available


  30. KOSKINAS KC, Zaugg S, Yamaji K, Garcia-Garcia HM, et al
    Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Atherosclerosis. 2016;247:154-160.
    PubMed     Text format     Abstract available


  31. MULDERS TA, Taraboanta C, Franken LC, van Heel E, et al
    Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease.
    Atherosclerosis. 2016;245:155-60.
    PubMed     Text format     Abstract available


  32. GUO L, Wang L, Li H, Yang X, et al
    Down regulation of GALNT3 contributes to endothelial cell injury via activation of p38 MAPK signaling pathway.
    Atherosclerosis. 2016;245:94-100.
    PubMed     Text format     Abstract available


  33. OLSON F, Engborg J, Gronhoj MH, Sand NP, et al
    Association between high-sensitive troponin I and coronary artery calcification in a Danish general population.
    Atherosclerosis. 2016;245:88-93.
    PubMed     Text format     Abstract available


  34. SUH B, Park S, Shin DW, Ahn H, et al
    Early repolarization is associated with significant coronary artery stenosis in asymptomatic adults.
    Atherosclerosis. 2016;245:50-3.
    PubMed     Text format     Abstract available


  35. VAGNARELLI F, Corsini A, Lorenzini M, Ortolani P, et al
    Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes.
    Atherosclerosis. 2016;245:43-9.
    PubMed     Text format     Abstract available


  36. CRAIEM D, Chironi DG, Casciaro ME, Sirieix ME, et al
    Association of thoracic aorta calcium and non cardiac vascular events in cardiac disease-free individuals.
    Atherosclerosis. 2016;245:22-7.
    PubMed     Text format     Abstract available


    January 2016
  37. LISOWSKA A, Knapp M, Tycinska A, Motybel E, et al
    Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study.
    Atherosclerosis. 2016;246:309-317.
    PubMed     Text format     Abstract available


  38. REINER Z, De Backer G, Fras Z, Kotseva K, et al
    Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries - Findings from the EUROASPIRE IV survey.
    Atherosclerosis. 2016;246:243-250.
    PubMed     Text format     Abstract available


  39. CHEN S, Wang X, Wang J, Zhao Y, et al
    Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction.
    Atherosclerosis. 2016;246:148-156.
    PubMed     Text format     Abstract available


  40. SUTTER I, Klingenberg R, Othman A, Rohrer L, et al
    Decreased phosphatidylcholine plasmalogens - A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction.
    Atherosclerosis. 2016;246:130-140.
    PubMed     Text format     Abstract available


  41. OGITA M, Miyauchi K, Kasai T, Tsuboi S, et al
    Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
    Atherosclerosis. 2016;244:216-21.
    PubMed     Text format     Abstract available


  42. SAELY CH, Leiherer A, Muendlein A, Vonbank A, et al
    High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis.
    Atherosclerosis. 2016;244:38-43.
    PubMed     Text format     Abstract available


    December 2015
  43. RASMUSSEN KL, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R, et al
    Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population.
    Atherosclerosis. 2015;246:63-70.
    PubMed     Text format     Abstract available


  44. MICHOS ED, Lutsey PL
    25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?
    Atherosclerosis. 2015 Dec 15. pii: S0021-9150(15)30225.
    PubMed     Text format    


  45. RHEE EJ, Kim JH, Park HJ, Park SE, et al
    Increased risk for development of coronary artery calcification in insulin-resistant subjects who developed diabetes: 4-year longitudinal study.
    Atherosclerosis. 2015;245:132-138.
    PubMed     Text format     Abstract available


    November 2015
  46. LAUGSAND LE, Asvold BO, Vatten LJ, Janszky I, et al
    Soluble CXCL16 and risk of myocardial infarction: The HUNT study in Norway.
    Atherosclerosis. 2015;244:188-194.
    PubMed     Text format     Abstract available


  47. CHEN X, Bakillah A, Zhou L, Pan X, et al
    Nitrated apolipoprotein AI/apolipoprotein AI ratio is increased in diabetic patients with coronary artery disease.
    Atherosclerosis. 2015;245:12-21.
    PubMed     Text format     Abstract available


  48. NARGESI AA, Heidari B, Esteghamati S, Hafezi-Nejad N, et al
    Contribution of vitamin D deficiency to the risk of coronary heart disease in subjects with essential hypertension.
    Atherosclerosis. 2015;244:165-171.
    PubMed     Text format     Abstract available


  49. WAKIL SM, Ram R, Muiya NP, Mehta M, et al
    A genome-wide association study reveals susceptibility loci for myocardial infarction/coronary artery disease in Saudi Arabs.
    Atherosclerosis. 2015;245:62-70.
    PubMed     Text format     Abstract available


  50. PITHA J, Kralova Lesna I, Hubacek JA, Sekerkova A, et al
    Smoking impairs and circulating stem cells favour the protective effect of the T allele of the connexin37 gene in ischemic heart disease - A multinational study.
    Atherosclerosis. 2015;244:73-78.
    PubMed     Text format     Abstract available


  51. BOEY E, Gay GM, Poh KK, Yeo TC, et al
    Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: A 5-year follow-up study.
    Atherosclerosis. 2015;244:86-92.
    PubMed     Text format     Abstract available


  52. ANTIOCHOS P, Marques-Vidal P, McDaid A, Waeber G, et al
    Association between parental history and genetic risk scores for coronary heart disease prediction: The population-based CoLaus study.
    Atherosclerosis. 2015;244:59-65.
    PubMed     Text format     Abstract available


    October 2015
  53. PARK M, Kulkarni A, Beatty A, Ganz P, et al
    Soluble endothelial cell selective adhesion molecule and cardiovascular outcomes in patients with stable coronary disease: A report from the Heart and Soul Study.
    Atherosclerosis. 2015;243:546-552.
    PubMed     Text format     Abstract available


  54. IMHOF A, Koenig W, Jaensch A, Mons U, et al
    Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease.
    Atherosclerosis. 2015;243:414-420.
    PubMed     Text format     Abstract available


  55. PURI R, Nissen SE, Menon V, Shao M, et al
    Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.
    Atherosclerosis. 2015;243:553-559.
    PubMed     Text format     Abstract available


    September 2015
  56. MOURA FA, Figueiredo VN, Teles BS, Barbosa MA, et al
    Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
    Atherosclerosis. 2015;243:124-130.
    PubMed     Text format     Abstract available


  57. SHIN DG, Han SM, Kim DI, Rhee MY, et al
    Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
    Atherosclerosis. 2015;243:53-58.
    PubMed     Text format     Abstract available


  58. TZIOMALOS K, Giampatzis V, Bouziana SD, Spanou M, et al
    Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke.
    Atherosclerosis. 2015;243:65-70.
    PubMed     Text format     Abstract available


  59. MONNERET D
    Evaluation of HbA1c as a prognostic biomarker of cardiovascular events and mortality in nondiabetic patients: Methodological considerations.
    Atherosclerosis. 2015;242:19-21.
    PubMed     Text format    


  60. BARKAS F, Elisaf M, Milionis H
    Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis.
    Atherosclerosis. 2015;243:60-64.
    PubMed     Text format     Abstract available


    August 2015
  61. YU HH, Chen PC, Yang YH, Wang LC, et al
    Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
    Atherosclerosis. 2015;243:11-18.
    PubMed     Text format     Abstract available


    July 2015
  62. PRUDENTE S, Bailetti D, Mendonca C, Mannino GC, et al
    Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.
    Atherosclerosis. 2015;242:334-339.
    PubMed     Text format     Abstract available


  63. TANAKA A, Ishii H, Oshima H, Narita Y, et al
    Inverse association between diabetes and aortic dilatation in patients with advanced coronary artery disease.
    Atherosclerosis. 2015;242:123-127.
    PubMed     Text format     Abstract available


  64. GARG PK, McClelland RL, Jenny NS, Criqui MH, et al
    Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
    Atherosclerosis. 2015;241:176-82.
    PubMed     Text format     Abstract available


  65. CREA F, Battipaglia I, Andreotti F
    Sex differences in mechanisms, presentation and management of ischaemic heart disease.
    Atherosclerosis. 2015;241:157-68.
    PubMed     Text format     Abstract available


  66. SUN Y, He J, Tian J, Xie Z, et al
    Association of circulating levels of neopterin with non-culprit plaque vulnerability in CAD patients an angiogram, optical coherent tomography and intravascular ultrasound study.
    Atherosclerosis. 2015;241:138-42.
    PubMed     Text format     Abstract available


  67. CASELLI C, De Graaf MA, Lorenzoni V, Rovai D, et al
    HDL cholesterol, leptin and interleukin-6 predict high risk coronary anatomy assessed by CT angiography in patients with stable chest pain.
    Atherosclerosis. 2015;241:55-61.
    PubMed     Text format     Abstract available


  68. MILASINOVIC D, Milosevic A, Marinkovic J, Vukcevic V, et al
    Timing of invasive strategy in NSTE-ACS patients and effect on clinical outcomes: A systematic review and meta-analysis of randomized controlled trials.
    Atherosclerosis. 2015;241:48-54.
    PubMed     Text format     Abstract available


  69. ROSSETTI HC, Weiner M, Hynan LS, Cullum CM, et al
    Subclinical atherosclerosis and subsequent cognitive function.
    Atherosclerosis. 2015;241:36-41.
    PubMed     Text format     Abstract available


    June 2015
  70. RAGGI P
    Left ventricular size as a predictor of vascular events.
    Atherosclerosis. 2015;240:398-9.
    PubMed     Text format    


  71. BITTENCOURT MS, Peixoto D
    Atherosclerosis in HIV patients: a different disease or more of the same?
    Atherosclerosis. 2015;240:333-4.
    PubMed     Text format    


  72. TOUTOUZAS K, Chatzizisis YS, Riga M, Giannopoulos A, et al
    Accurate and reproducible reconstruction of coronary arteries and endothelial shear stress calculation using 3D OCT: comparative study to 3D IVUS and 3D QCA.
    Atherosclerosis. 2015;240:510-9.
    PubMed     Text format     Abstract available


    May 2015
  73. RHEE EJ, Park SE, Oh HG, Park CY, et al
    Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort.
    Atherosclerosis. 2015;240:242-9.
    PubMed     Text format     Abstract available


  74. OTHMAN A, Saely CH, Muendlein A, Vonbank A, et al
    Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
    Atherosclerosis. 2015;240:216-21.
    PubMed     Text format     Abstract available


  75. PAPAFAKLIS MI, Takahashi S, Antoniadis AP, Coskun AU, et al
    Effect of the local hemodynamic environment on the de novo development and progression of eccentric coronary atherosclerosis in humans: insights from PREDICTION.
    Atherosclerosis. 2015;240:205-11.
    PubMed     Text format     Abstract available


  76. D'ASCENZO F, Cerrato E, Calcagno A, Grossomarra W, et al
    High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis.
    Atherosclerosis. 2015;240:197-204.
    PubMed     Text format     Abstract available


  77. AKBOGA MK, Canpolat U, Sahinarslan A, Alsancak Y, et al
    Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation.
    Atherosclerosis. 2015;240:110-4.
    PubMed     Text format     Abstract available


  78. GAZTANAGA J, Farkouh M, Rudd JH, Brotz TM, et al
    A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome.
    Atherosclerosis. 2015;240:53-60.
    PubMed     Text format     Abstract available


  79. DYKUN I, Geisel MH, Kalsch H, Lehmann N, et al
    Association of computed tomography-derived left ventricular size with major cardiovascular events in the general population: the Heinz Nixdorf recall study.
    Atherosclerosis. 2015;240:46-52.
    PubMed     Text format     Abstract available


  80. BIELINSKI SJ, Berardi C, Decker PA, Kirsch PS, et al
    P-selectin and subclinical and clinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2015;240:3-9.
    PubMed     Text format     Abstract available


    April 2015
  81. DE BACKER G, Besseling J, Chapman J, Hovingh GK, et al
    Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology.
    Atherosclerosis. 2015;241:169-175.
    PubMed     Text format     Abstract available


  82. MINAME MH, Santos RD
    Fatty liver, inflamed blood and calcified coronary arteries: lessons and uncertainties from the multiethnic study of atherosclerosis -commentary on the study of Al Rifai et al.
    Atherosclerosis. 2015;239:634-6.
    PubMed     Text format    


  83. SOGUT E, Kadi H, Karayakali M, Mertoglu C, et al
    The association of plasma vitamin A and E levels with coronary collateral circulation.
    Atherosclerosis. 2015;239:547-51.
    PubMed     Text format     Abstract available


  84. VAN DER LAAN SW, Foroughi Asl H, van den Borne P, van Setten J, et al
    Variants in ALOX5, ALOX5AP and LTA4H are not associated with atherosclerotic plaque phenotypes: the Athero-Express Genomics Study.
    Atherosclerosis. 2015;239:528-38.
    PubMed     Text format     Abstract available


  85. RIZZA S, Copetti M, Cardellini M, Menghini R, et al
    A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis.
    Atherosclerosis. 2015;239:459-64.
    PubMed     Text format     Abstract available


  86. WEIJMANS M, de Bakker PI, van der Graaf Y, Asselbergs FW, et al
    Incremental value of a genetic risk score for the prediction of new vascular events in patients with clinically manifest vascular disease.
    Atherosclerosis. 2015;239:451-8.
    PubMed     Text format     Abstract available


  87. AL RIFAI M, Silverman MG, Nasir K, Budoff MJ, et al
    The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2015;239:629-33.
    PubMed     Text format     Abstract available


  88. HWANG IC, Jeon JY, Kim Y, Kim HM, et al
    Statin therapy is associated with lower all-cause mortality in patients with non-obstructive coronary artery disease.
    Atherosclerosis. 2015;239:335-42.
    PubMed     Text format     Abstract available


  89. ITO T, Fujita H, Tani T, Ohte N, et al
    Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent.
    Atherosclerosis. 2015;239:311-7.
    PubMed     Text format     Abstract available


  90. REIN P, Saely CH, Silbernagel G, Vonbank A, et al
    Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease.
    Atherosclerosis. 2015;239:299-303.
    PubMed     Text format     Abstract available


    February 2015
  91. REBNORD EW, Pedersen ER, Strand E, Svingen GF, et al
    Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: A prospective cohort study.
    Atherosclerosis. 2015;240:115-120.
    PubMed     Text format     Abstract available


  92. CAVUSOGLU E, Marmur JD, Chhabra S, Hojjati MR, et al
    Elevated baseline plasma phospholipid protein (PLTP) levels are an independent predictor of long-term all-cause mortality in patients with diabetes mellitus and known or suspected coronary artery disease.
    Atherosclerosis. 2015;239:503-508.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: